a trend towards significanceP = 0.057
For the 1-spray group, at week 12, the severity decreased by −1.04 compared to −0.26 ± 0.60 in the placebo group ( P < 0.001) and there was a trend towards significance at week 4 ( P = 0.057).
For the 1-spray group, at week 12, the severity decreased by −1.04 compared to −0.26 ± 0.60 in the placebo group ( P < 0.001) and there was a trend towards significance at week 4 ( P = 0.057).